News Image

Wednesday's session: top gainers and losers

By Mill Chart

Last update: Sep 28, 2022

Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session.

Today's top gainers

TickerChangeComment
PRTA75.4%PROTHENA CORP PLC's (NASDAQ:PRTA) shares rose 75.4% to $54.25. In the last 6 months the stock lost 20.81%.
SOBR62.96%SOBR SAFE INC (NASDAQ:SOBR) rose 62.96% to $2.2 during Wednesday's after hours session. The stock is trading 27.96% higher than a month ago.
BTRS60.4%BTRS HOLDINGS INC-CL 1's (NASDAQ:BTRS) stock price increased by 60.4% to $9.26. Earlier today the company had a press release: BTRS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of BTRS Holdings Inc. Is Fair to Shareholders.
FNGR57.55%FINGERMOTION INC's (NASDAQ:FNGR) stock price is advancing with 57.55% to a price of $1.67. The stock is trading 21.54% lower than 3 months ago.
BIIB39.02%BIOGEN INC's (NASDAQ:BIIB) shares rose 39.02% to $274.97. In the last year the stock lost 30.34%.
BEAT33.43%HEARTBEAM INC's (NASDAQ:BEAT) shares rose 33.43% to $3.59 during Wednesday's session. Earlier today the company had a press release: HeartBeam Granted Patent for Signal Transformation from Vector Electrocardiogram (VECG) to 12-Lead Electrocardiogram (ECG).
QTRX32.36%QUANTERIX CORP's (NASDAQ:QTRX) shares rose 32.36% to $10.67 during Wednesday's session. The stock is trading 52.0% lower than 3 months ago.
KLXE28.79%KLX ENERGY SERVICES HOLDING's (NASDAQ:KLXE) stock price is advancing with 28.79% to a price of $6.89. The stock is trading 35.15% lower than a month ago.
STIM24.37%NEURONETICS INC's (NASDAQ:STIM) shares rose 24.37% to $2.96 during Wednesday's session. The stock is trading 38.66% lower than a month ago.
TOPS24.37%TOP SHIPS INC (NASDAQ:TOPS) rose 24.37% to $2.91 during Wednesday's after hours session. Shareholders saw the stock price going 59.84% lower in the past month.

To see the full list of top gainers you can use our top gainers screener.

Top losers

TickerChangeComment
PHAS-65.01%PHASEBIO PHARMACEUTICALS INC's (NASDAQ:PHAS) stock price is declining with 65.01% to a price of $0.27. In the last month the share price dropped with 32.74%.
MNMD-50.41%MIND MEDICINE MINDMED INC's (NASDAQ:MNMD) stock price is declining with 50.41% to a price of $3.04. In the last month the stock lost 49.04%.
IBIO-35.41%IBIO INC's (NYSEARCA:IBIO) stock price decreased by 35.41% to $0.2. In the last 3 months the stock gained 21.54%.
NA-33.02%NANO LABS LTD-ADR's (NASDAQ:NA) stock price decreased by 33.02% to $2.13. A press release (Nano Labs Ltd Announces Pricing of Public Offering of American Depositary Shares) was released yesterday.
HLBZW-31.14%HELBIZ INC-CW24's (NASDAQ:HLBZW) shares fell 31.14% to $0.07 during Wednesday's session. In the last 6 months the share price dropped with 65.67%.
GROV-25.71%GROVE COLLABORATIVE HOLDINGS's (NYSE:GROV) stock price is declining with 25.71% to a price of $2.98. Yesterday the company had a press release: Grove Co. Continues Retail Expansion with Entry Into Thousands of More Stores.
SONX-22.75%SONENDO INC's (NYSE:SONX) stock price is declining with 22.75% to a price of $1.29. In the last month the share price increased with 41.53%.
ALLG-22.62%ALLEGO NV's (NYSE:ALLG) stock price is declining with 22.62% to a price of $4.55. The stock is trading 51.55% higher than a month ago.
REVBW-21.82%REVELATION BIOSC -CW27's (NASDAQ:REVBW) shares fell 21.82% to $0.04. In the last month the stock lost 38.43%.
LYLT-21.71%LOYALTY VENTURES INC's (NASDAQ:LYLT) shares fell 21.71% to $1.37 during Wednesday's session. The stock is trading 21.88% lower than a month ago.

For the full top loser list go to our top losers screener.

Back

NEURONETICS INC

NASDAQ:STIM (3/28/2024, 8:00:01 PM)

4.76

-0.04 (-0.83%)

STIM News

News Imagea day ago - NeuroneticsNeuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., March 27, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing,...

News Image4 days ago - NeuroneticsNeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression

NeuroStar is the first and only TMS therapy cleared as an adjunct treatment for patients ages 15 and older

News Image4 days ago - NeuroneticsNeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression

NeuroStar is the first and only TMS therapy cleared as an adjunct treatment for patients ages 15 and older...

News Image22 days ago - NeuroneticsNeuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network
News Image22 days ago - NeuroneticsNeuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network

MALVERN, Pa., March 07, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and...

News Image24 days ago - NeuroneticsNeuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating Results

MALVERN, Pa., March 05, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology...

News Imagea month ago - NeuroneticsNeuronetics to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call

MALVERN, Pa., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced that it plans to release fourth quarter 2023 financial and operating results prior to market open on Tuesday, March 5th, 2024. The Company will host a conference call to review its results at 8:30 a.m. Eastern Time the same day.

News Image2 months ago - NeuroneticsNeuronetics Launches Latest Evolution in its TrakStar® Patient Data Management System

Advancements provide workflow efficiencies for NeuroStar® TMS providers

News Image2 months ago - NeuroneticsNeuronetics Launches Latest Evolution in its TrakStar® Patient Data Management System

Advancements provide workflow efficiencies for NeuroStar® TMS providers...

News Image2 months ago - NeuroneticsNeuroStar TMS Patient Access Expands Through Lucet Health Policy Update

Criteria Change Reduces Requirements for Treatment Accessibility

News Image2 months ago - NeuroneticsNeuroStar TMS Patient Access Expands Through Lucet Health Policy Update

Criteria Change Reduces Requirements for Treatment Accessibility...

News Image3 months ago - Seeking AlphaNeuronetics expects preliminary Q4 revenue to be over $20M (NASDAQ:STIM)

Neuronetics reports preliminary Q4 2023 revenue of over $20 million, exceeding guidance, with positive cash flow and strong year-end financials.

STIM Links
Follow us for more